Oritavancin Diphosphate 400 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 400 mg
Reference Brands: Orbactiv (USA)
Category: Antibiotics
Oritavancin Diphosphate is a Antibiotics product available as Injection in strengths 400 mg. It corresponds to the reference brand Orbactiv (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Oritavancin, marketed under the brand name Orbactiv, is a semisynthetic glycopeptide antibiotic used for the treatment of serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA). Structurally related to vancomycin, it is a lipoglycopeptide that inhibits bacterial cell wall synthesis and disrupts membrane integrity, leading to rapid bacterial cell death.
Oritavancin is considered a long-acting antibiotic due to its extended half-life of up to 16 days and high plasma protein binding (~85%), which allows for sustained therapeutic concentrations in tissues. The drug demonstrates excellent tissue penetration, including skin structures, synovial fluid, bone tissue, and macrophages, making it effective in treating complex infections. Its pharmacokinetic properties enable less frequent dosing while maintaining potent activity against Gram-positive pathogens.
These features make oritavancin a convenient option for outpatient therapy, particularly in populations where adherence may be challenging or access to healthcare is limited. It is suitable for prolonged courses in infections such as osteoarticular infections, endocarditis, and other deep-seated Gram-positive infections. Oritavancin should be administered under specialist supervision to ensure optimal efficacy and patient safety.
Oritavancin Diphosphate — third party manufacturing & bulk supply
Oritavancin Diphosphate 400 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Oritavancin Diphosphate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Oritavancin Diphosphate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Oritavancin diphosphate is used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including MRSA.
Oritavancin diphosphate is a semisynthetic lipoglycopeptide antibiotic derived from a naturally occurring glycopeptide compound, formulated as a sterile injectable powder.
The trade name is Orbactiv.
Orbactiv is marketed by Melinta Therapeutics (USA).
The complete generic name is oritavancin diphosphate.
The approved brand name is Orbactiv.
Oritavancin diphosphate is manufactured in GMP-approved facilities in the USA and other regulated pharmaceutical manufacturing regions, depending on the authorized supplier.
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View DetailsCeftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers